Oppenheimer Increased its Price Target on Amrize Ltd (AMRZ) to $70 and Maintains an Outperform Rating
I'm PortAI, I can summarize articles.
Oppenheimer has raised its price target on Amrize Ltd (NYSE:AMRZ) to $70 from $64, maintaining an Outperform rating. This adjustment follows the company's Q4 2025 EBITDA report of $779M. Amrize Ltd is also listed among the 11 Newly-Listed NYSE Stocks to Buy Now.
Source: MSN The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments